Oric Pharma director Richard A. Heyman disposes of common shares worth $86,518.47

ORIC•2026-10-02

Director Richard A. Heyman exercised options for 3,500 Oric Pharmaceuticals shares at $1.60 each on Oct. 1, 2026, and sold 3,500 shares at $12.9141. RAHD Capital sold 3,200 shares at the same price.

1. Share transactions

After the transactions, Heyman directly owned 38,300 shares. RAHD Capital, LLC held 203,472 shares indirectly.

Sources

Oric Pharma director Richard A. Heyman disposes of common shares worth $86,518.47

Sec

Oric Pharma director Richard A. Heyman disposes of common shares worth $86,518.47

1. Share transactions

Related News

Alphabet director Frances Arnold sells $28,257 of Class C shares

Alkermes EVP, CLO David Joseph Gaffin disposes of 2,034 common shares worth $83,464.02

Wheeler REIT director Joseph Stilwell disposes of 5 common shares worth $15.15

Sources

Oric Pharma director Richard A. Heyman disposes of common shares worth $86,518.47

AvePoint chief legal officer Brian Michael Brown sells $141,100 in common shares

UGI unit issues $30 million of 5.95% senior notes due Sept. 28, 2038